Goals for Reaching Optimal Wellness: GROWell
达到最佳健康的目标:GROWell
基本信息
- 批准号:10025267
- 负责人:
- 金额:$ 52.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-26 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdherenceAdultAgeAlgorithmsAnxietyBehavior monitoringBehavioralBirthBlindedBody Weight decreasedBody mass indexBreast FeedingCategoriesCellular PhoneCesarean sectionChildChildbirthClinicDietEducationEnergy IntakeEnrollmentFeedbackFemaleFetal GrowthFoodFrequenciesGestational AgeGestational DiabetesGoalsGuidelinesHealthHumanIndividualInfantInformal Social ControlInstitute of Medicine (U.S.)InternetInterventionLinkMaternal and Child HealthMeasuresMental DepressionMethodologyMonitorMothersNutrientObesityOccupationsOverweightParticipantPhysical activityPostpartum PeriodPre-EclampsiaPregnancyPregnancy ComplicationsPregnancy OutcomePregnant WomenPremature BirthProblem SolvingPublic HealthRaceRandomizedRandomized Controlled TrialsRecipeRecommendationReportingResearchResourcesRiskSelf CareSmall for Gestational Age InfantTechnologyTestingTextText MessagingTimeWeightWeight GainWeight maintenance regimenWomanWomen&aposs HealthWorkarmattentional controlbaseclinical careclinical practiceclinical research sitecomparative efficacydemographicsdesignefficacy testingevidence basegestational weight gainimprovedinfancyinnovationmHealthmaternal outcomemeetingsmembermother nutritionneonatal outcomeobesity treatmentobstetric outcomesparitypostpartum weightprenatalprepregnancyprepregnancy obesitypreventrecruitretention rateskillssocial mediatheoriestoolweight maintenanceyoung adult
项目摘要
Research attempts to prevent excess gestational weight gain, defined as gaining more weight during
pregnancy than Institute of Medicine (IOM) guidelines for prepregnancy body mass index (BMI), have largely
been unsuccessful. Roughly 62% of overweight and 45% of obese women still gain more weight than
recommended, increasing risk for postpartum weight retention. Few mobile health (mHealth) interventions
have been trialed to address pregnancy-associated weight gain, which is a missed opportunity. Adult women
are high users of technology for general and pregnancy-specific health information seeking and sharing. To fill
this gap, our long-term goal is to disseminate into clinical practice a standalone mHealth tool that is effective
for overweight and obese pregnant women to achieve gestational weight gain within IOM recommendations
and return to prepregnancy weight after childbirth. The goal of this application is to test GROWell: Goals for
Reaching Optimal Wellness, an innovative, mHealth tool based on Self-regulation Theory that we designed in
pilot work to achieve appropriate gestational weight gain and safe postpartum weight loss. We propose a
blinded randomized controlled trial to test the efficacy of GROWell compared to an attention control also
developed in our pilot. We will recruit 480 women ages 18-44 with prepregnancy BMI 25-<40 and 10-16 weeks
gestation of a singleton, uncomplicated pregnancy. Block randomization based on BMI, race, and recruitment
clinic will be used to assign participants equally to arm 1, GROWell (n=240), or arm 2, the attention control
(n=240). Upon study enrollment and through 6 months postpartum, GROWell participants will receive daily text
messages that provide tailored education, problem-solving skills, and support to aid their personalized dietary
goals. Once weekly, participants self-monitor overall adherence to their goals using text messages that prompt
them to report on how they did in the past week. When users respond to this prompt, they immediately receive
a text with tailored feedback on their adherence and long-term progress toward their goals. Control participants
will receive weekly texts that provide personalized self-care, pregnancy, labor, delivery, and early infancy
education. The specific aims are to: (1) Compare the efficacy of GROWell to the attention control in reducing
the proportion of women who gain excess gestational weight based on IOM guidelines (>25 lbs for overweight
and >20 lbs for obese) controlling for demographics, parity, physical activity, diet quality, and
depression/anxiety; and (2) Compare the efficacy of GROWell to the attention control in reducing postpartum
weight retention at 6 months post-birth as measured by the proportion of women who are within 5% of their
prepregnancy weight, controlling for demographics, parity, physical activity, diet quality, breastfeeding, and
depression/anxiety. This research addresses PA 18-135 (Maternal Nutrition and Pre-pregnancy Obesity) and
will provide an innovative, evidence-based, standalone mHealth tool to reduce excess gestational weight gain
and postpartum weight retention among overweight and obese women, currently an unavailable resource.
研究试图防止妊娠期体重过度增加,定义为在怀孕期间增加更多的体重。
怀孕比医学研究所(IOM)的孕前体重指数(BMI)指南,在很大程度上
没有成功。大约62%的超重妇女和45%的肥胖妇女体重仍然增加,
建议,增加产后体重保持的风险。移动的保健干预措施很少
已经尝试解决怀孕相关的体重增加,这是一个错过的机会。成年妇女
在寻求和分享一般和具体妊娠健康信息方面,妇女是技术的高度使用者。填补
为了弥补这一差距,我们的长期目标是在临床实践中传播一种有效的独立移动健康工具,
超重和肥胖孕妇达到IOM建议的妊娠期体重增加
并在分娩后恢复到怀孕前的体重。此应用程序的目标是测试GROWell:
达到最佳健康,一个创新的,移动健康工具的基础上自我调节理论,我们设计的,
开展试点工作,以实现适当的妊娠期体重增加和安全的产后体重减轻。我们提出了一个
盲法随机对照试验,以测试GROWell与注意力对照相比的疗效,
在我们的飞行员。我们将招募480名年龄在18-44岁之间,孕前BMI 25-<40,孕10-16周的女性。
单胎妊娠,无并发症。基于BMI、人种和招募的区组随机化
将使用诊所将受试者平等分配至第1组GROWell(n=240)或第2组注意力控制组
(n=240)。在研究入组后和产后6个月内,GROWell参与者将接受每日文本
提供量身定制的教育,解决问题的技能和支持,以帮助他们个性化的饮食信息,
目标.每周一次,参与者通过短信自我监测他们对目标的总体坚持程度,
让他们报告他们在过去一周的表现。当用户响应此提示时,他们立即收到
一个文本,其中包含针对他们的坚持和实现目标的长期进展的定制反馈。对照参与者
每周都会收到短信,提供个性化的自我护理,怀孕,分娩,分娩和婴儿早期
教育具体目的是:(1)比较GROWell与注意控制在降低
根据IOM指南,妊娠期体重增加过多的妇女比例(>25磅为超重
和>20磅的肥胖),控制人口统计学、产次、体力活动、饮食质量,
(2)比较GROWell与注意力控制在减少产后抑郁/焦虑方面的疗效
出生后6个月的体重保持率,以体重保持率在5%以内的妇女比例衡量,
孕前体重,控制人口统计学、产次、体力活动、饮食质量、母乳喂养,
抑郁/焦虑。本研究涉及PA 18-135(孕产妇营养和孕前肥胖),
将提供一个创新的,以证据为基础的,独立的移动健康工具,以减少过度妊娠体重增加
以及超重和肥胖妇女的产后体重保持率,这是目前无法获得的资源。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Leigh Ann Simmons其他文献
Leigh Ann Simmons的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Leigh Ann Simmons', 18)}}的其他基金
Goals for Reaching Optimal Wellness: GROWell
达到最佳健康的目标:GROWell
- 批准号:
10437737 - 财政年份:2019
- 资助金额:
$ 52.31万 - 项目类别:
Goals for Reaching Optimal Wellness: GROWell
达到最佳健康的目标:GROWell
- 批准号:
10647821 - 财政年份:2019
- 资助金额:
$ 52.31万 - 项目类别:
Goals for Reaching Optimal Wellness: GROWell
达到最佳健康的目标:GROWell
- 批准号:
10222784 - 财政年份:2019
- 资助金额:
$ 52.31万 - 项目类别:
相似海外基金
Structural Racism, Pharmacy Closures and Disparities in Medication Adherence Among Older Adult Medicare Part-D Beneficiaries
结构性种族主义、药房关闭以及老年人医疗保险 D 部分受益人的药物依从性差异
- 批准号:
10568717 - 财政年份:2023
- 资助金额:
$ 52.31万 - 项目类别:
Medication Adherence and Cardio-Metabolic Control Indicators among Adult American Indians Receiving Tribal Health Services
接受部落卫生服务的成年美洲印第安人的药物依从性和心脏代谢控制指标
- 批准号:
10419967 - 财政年份:2022
- 资助金额:
$ 52.31万 - 项目类别:
Medication Adherence and Cardio-Metabolic Control Indicators among Adult American Indians Receiving Tribal Health Services
接受部落卫生服务的成年美洲印第安人的药物依从性和心脏代谢控制指标
- 批准号:
10592441 - 财政年份:2022
- 资助金额:
$ 52.31万 - 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
- 批准号:
10369750 - 财政年份:2021
- 资助金额:
$ 52.31万 - 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
- 批准号:
10633248 - 财政年份:2021
- 资助金额:
$ 52.31万 - 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
- 批准号:
10487516 - 财政年份:2021
- 资助金额:
$ 52.31万 - 项目类别:
Mhealth for Pre-exposure Prophylaxis Adherence by Young Adult MSM
Mhealth 促进年轻 MSM 遵守暴露前预防
- 批准号:
10228564 - 财政年份:2018
- 资助金额:
$ 52.31万 - 项目类别:
Mhealth for Pre-exposure Prophylaxis Adherence by Young Adult MSM
Mhealth 促进年轻 MSM 遵守暴露前预防
- 批准号:
9347041 - 财政年份:2017
- 资助金额:
$ 52.31万 - 项目类别:
Mindfulness training with HIV-positive youth and adult family members to improve treatment adherence
对艾滋病毒呈阳性的青少年和成年家庭成员进行正念训练,以提高治疗依从性
- 批准号:
9480702 - 财政年份:2016
- 资助金额:
$ 52.31万 - 项目类别:
Mindfulness training with HIV-positive youth and adult family members to improve treatment adherence
对艾滋病毒呈阳性的青少年和成年家庭成员进行正念训练,以提高治疗依从性
- 批准号:
9906853 - 财政年份:2016
- 资助金额:
$ 52.31万 - 项目类别: